<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJMN</journal-id><journal-title-group><journal-title>Open Journal of Modern Neurosurgery</journal-title></journal-title-group><issn pub-type="epub">2163-0569</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojmn.2017.73008</article-id><article-id pub-id-type="publisher-id">OJMN-77422</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Intracranial Intermediate-Grade Melanocytic Neoplasm: Case Report Associated with Nevus of Ota
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Dorothy</surname><given-names>Sze Wing Hung</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Calvin</surname><given-names>Hoi Kwan Mak</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Fung</surname><given-names>Ching Cheung</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Neurosurgery, Queen Elizabeth Hospital, Hong Kong, China</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>calvinmakhk@yahoo.com(CHKM)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>23</day><month>06</month><year>2017</year></pub-date><volume>07</volume><issue>03</issue><fpage>65</fpage><lpage>74</lpage><history><date date-type="received"><day>June</day>	<month>2,</month>	<year>2017</year></date><date date-type="rev-recd"><day>Accepted:</day>	<month>July</month>	<year>2,</year>	</date><date date-type="accepted"><day>July</day>	<month>5,</month>	<year>2017</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Melanocytic lesions of the CNS are rare tumours originating from melanocytes that are present in the leptomeninges. They consist of a spectrum of pigmented 
  tumours ranging from melanocytoma to melanoma. A small group of these tumours have histopathological features between those of a benign melanocytoma and a malignant melanoma; these present as intermediate grade melanocytic neoplasms. Naevus of Ota is a blue hyperpigmented dermal lesion characterized by increased number of melanocytes in the distribution of ophthalmic and maxillary divisions of the trigeminal nerve. The association of an intracranial intermediate-grade melanocytic neoplasm with a nevus of Ota is extremely rare, with only 2 cases reported in the literature to date. As a result, their behavior and progression are still poorly understood. We present the first case of a familial naevus of Ota associated with intermediate-grade melanocytic neoplasm.
 
</p></abstract><kwd-group><kwd>Melanocytic Neoplasm</kwd><kwd> Leptomeninges</kwd><kwd> Nevus of Ota</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Case Report</title><p>A 50-year-old female with good past health presented to Queen Elizabeth Hospital on 7<sup>th</sup> April, 2016, with fall and left side weakness.</p><p>Upon presentation, her vitals were stable. She was fully conscious and orientated, with right side pupil measuring 4 mm and left side 3 mm. There was no deficit of other cranial nerves. She suffered from dense left hemiplegia without sensory deficit. Plain computer tomography (CT) of brain demonstrated a 4 cm right temporal hyperdense lesion with local mass effect (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><p>Emergency craniotomy and gross total excision of the lesion were performed.</p><fig-group id="fig1"><label><xref ref-type="fig" rid="fig1">Figure 1</xref></label><caption><title> CT brain upon admission showing right temporal haemorrhage.</title></caption><fig id ="fig1_1"><label></label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/4-2080188x2.png"/></fig><fig id ="fig1_2"><label></label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/4-2080188x3.png"/></fig></fig-group><p>Intraoperative findings were suggestive of a pigmented lesion with haemorrhage, displacing the right internal carotid artery, right middle cerebral artery, and right third nerve.</p><p>Histopathological examination later revealed features of a melanocytic proliferation with worrisome histologic features including elevated mitosis and focal atypia, but no necrosis or anaplasia. Final pathological diagnosis was intermediate grade melanocytic neoplasm. On immunohistochemistry the tumour cells showed diffuse and strong positivity for HMB45 and patchy expression of S-100 protein. BRAF gene mutation was negative.</p><p>A detailed head-to-toe physical examination showed a left eyebrow pigmented naevus in the distribution of cranial nerve V1, which has been present without change for many years. There were no other suspicious melanocytic lesions. The patient had no family history of melanoma.</p><p>In view of the intracranial findings, an incisional biopsy of the eyebrow lesion was performed. The final pathology was dermal dendritic melanocytosis, which can be compatible with the diagnosis of naevus of Ota.</p><p>The patient further underwent whole body PET-CT and CT angiography of the brain. Both showed unremarkable findings.</p><p>Upon further questioning, the patient revealed that her 21-year-old son also has a similar left eyebrow pigmented lesion, which has been present for 3 years with no change in appearance. He had unremarkable past medical history. We performed an MRI of the brain for him, which was unremarkable.</p><p>Following the operation, the patient had transient right third nerve palsy (<xref ref-type="fig" rid="fig2">Figure 2</xref>), which spontaneously resolved at 3 months. Follow up MRI brain showed no recurrence at 4 months and 8 months after operation (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Upon follow up at the outpatient clinic 8 months post operatively, she had no neurological deficit, and has returned to work full-time as a hospital janitor.</p><fig id="fig2"  position="float"><label><xref ref-type="fig" rid="fig2">Figure 2</xref></label><caption><title> Patient with left naevus of Ota involving the distribution of the first (V1) branch of the trigeminal nerve. Post-operative 3<sup>rd</sup> nerve palsy is seen</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/4-2080188x4.png"/></fig><fig-group id="fig3"><label><xref ref-type="fig" rid="fig3">Figure 3</xref></label><caption><title> Follow up MRI 8 months post-operatively.</title></caption><fig id ="fig3_1"><label></label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/4-2080188x5.png"/></fig><fig id ="fig3_2"><label></label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/4-2080188x6.png"/></fig><fig id ="fig3_3"><label></label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/4-2080188x7.png"/></fig></fig-group></sec><sec id="s2"><title>2. Discussion</title><p>Melanocytes are of neural crest in origin. Melanocytic neoplasm of the CNS associated with naevus of Ota is a rare disease. The naevus of Ota is a blue pigmented lesion that involves unilateral skin or mucous membranes in areas supplied by the trigeminal nerve [<xref ref-type="bibr" rid="scirp.77422-ref1">1</xref>] . It is thought to develop when migration of melanoblasts is arrested at the dermis instead of the dermoepidermal junction. It has been speculated that intracranial melanocytoma associated with the naevus of Ota both originate from melanocytes derived from the neural crest.</p><p>Primary CNS melanocytic tumours represent a spectrum of disease from well-differentiated melanocytoma to malignant melanoma. These are rare tumours with an estimated incidence 0.9 per 10 million for melanocytomas and 0.5 cases per 10 million for primary malignant melanomas [<xref ref-type="bibr" rid="scirp.77422-ref2">2</xref>] . They are most commonly intracranial, but can involve the spinal column, where they are most often intradural and extramedullary [<xref ref-type="bibr" rid="scirp.77422-ref3">3</xref>] . A small group of these tumours have histopathological features between those of a benign melanocytoma and a malignant melanoma; these are labeled as intermediate grade melanocytic neoplasm [<xref ref-type="bibr" rid="scirp.77422-ref4">4</xref>] .</p></sec><sec id="s3"><title>3. Literature Review</title><p>Review of the literature revealed that melanocytoma and intermediate grade melanocytic lesions can recur as malignant melanoma despite complete excision [<xref ref-type="bibr" rid="scirp.77422-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.77422-ref6">6</xref>] . This supports the previously proposed theory of melanocytoma, intermediate grade melanocytic neoplasm, and malignant melanoma as a continuous spectrum of disease, rather than each being a separate disease entity. With this knowledge, it is important to review these three diagnoses in conjunction with a naevus of Ota.</p><p>Literature search via Pubmed and EMBASE revealed 11 previous cases of melanocytoma and 2 cases of intermediate grade melanocytic neoplasm to date, and at least 11 cases of melanoma have been reported in conjunction with naevus of Ota (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p>All reported cases of melanocytoma were ipsilateral to the naevus of Ota, where occasionally intermediate grade melanocytic neoplasms and melanoma have been found to occur contralateral to the cutaneous lesion. The reason for this is still largely unknown. We hypothesize that intracranial lesions that develop contralateral to the naevus of Ota may represent a more aggressive lesion and a different disease entity with higher risks of malignant transformation.</p><p>Management and outcome</p><p>Literature search showed that treatment options for patients with melanocytoma, intermediate grade melanocytic neoplasms, and melanomas were heterogeneous, with no established consensus. In most cases, patients underwent surgical excision, with a few cases also receiving radiotherapy or chemotherapy.</p><p>There have been few publications on the treatment of these neoplasms. Rades and colleagues published one of the more substantiated studies in 2004. The retrospective review of 89 meningeal melanocytomas showed that the five-year- survival rate was 100% in patients who received complete resection, but only</p><table-wrap-group id="1"><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> (a) Melanocytoma occurring in conjunction with a naevus of Ota, (b) Intermediate grade melanocytic neoplasm occurring in conjunction with a naevus of Ota, (c) Malignant melanoma occurring in conjunction with a naevus of Ota</title></caption><table-wrap id="1_1"><caption><title> (b)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Author/Year</th><th align="center" valign="middle" >Age/sex</th><th align="center" valign="middle" >Naevus of Ota</th><th align="center" valign="middle" >Site of intracranial lesion</th><th align="center" valign="middle" >Presenting symptoms</th><th align="center" valign="middle" >Excision</th><th align="center" valign="middle" >RT/chemo</th><th align="center" valign="middle" >Outcome</th></tr></thead><tr><td align="center" valign="middle" >Botticelli 1983 [<xref ref-type="bibr" rid="scirp.77422-ref7">7</xref>]</td><td align="center" valign="middle" >43/F</td><td align="center" valign="middle" >Left</td><td align="center" valign="middle" >Leftmeckel’s cave.</td><td align="center" valign="middle" >Left CN4 palsy, left ptosis, enophthalmos</td><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >Yes/No</td><td align="center" valign="middle" >Recur 2 years later, subtotal excision + RT. No more recurrence</td></tr><tr><td align="center" valign="middle" >Moon WS 1992 [<xref ref-type="bibr" rid="scirp.77422-ref8">8</xref>]</td><td align="center" valign="middle" >53/M</td><td align="center" valign="middle" >Right</td><td align="center" valign="middle" >Right parietooccipital, left frontal</td><td align="center" valign="middle" >Right hemiparesis, vomiting</td><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >No/No</td><td align="center" valign="middle" >Recurred</td></tr><tr><td align="center" valign="middle" >Piercecchi-Marti 2002 [<xref ref-type="bibr" rid="scirp.77422-ref9">9</xref>]</td><td align="center" valign="middle" >25/M</td><td align="center" valign="middle" >Right</td><td align="center" valign="middle" >Right frontoparietal</td><td align="center" valign="middle" >Strabismus, headache, grandma seizure</td><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >No/No</td><td align="center" valign="middle" >No recurrence</td></tr><tr><td align="center" valign="middle" >Rahimi 2003 [<xref ref-type="bibr" rid="scirp.77422-ref10">10</xref>]</td><td align="center" valign="middle" >17/M</td><td align="center" valign="middle" >Left</td><td align="center" valign="middle" >Left parietal</td><td align="center" valign="middle" >Headache, blindness</td><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >No/No</td><td align="center" valign="middle" >N/A</td></tr><tr><td align="center" valign="middle" >Rutten 2005 [<xref ref-type="bibr" rid="scirp.77422-ref11">11</xref>]</td><td align="center" valign="middle" >37/F</td><td align="center" valign="middle" >Right</td><td align="center" valign="middle" >Right olfactory groove</td><td align="center" valign="middle" >Headache, loss visual acuity</td><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >No/No</td><td align="center" valign="middle" >Multifocal recurrence, total excision &#224; RT. No more recurrence</td></tr><tr><td align="center" valign="middle" >Hino K 2005 [<xref ref-type="bibr" rid="scirp.77422-ref12">12</xref>]</td><td align="center" valign="middle" >75/F</td><td align="center" valign="middle" >Right</td><td align="center" valign="middle" >Right anterior clinoid process, intraorbital</td><td align="center" valign="middle" >Decreased vision, disturbed consciousness</td><td align="center" valign="middle" >Partial</td><td align="center" valign="middle" >No/No</td><td align="center" valign="middle" >No recurrence (but apallic state)</td></tr><tr><td align="center" valign="middle" >Hao Pan 2011 [<xref ref-type="bibr" rid="scirp.77422-ref13">13</xref>]</td><td align="center" valign="middle" >36/M</td><td align="center" valign="middle" >Right</td><td align="center" valign="middle" >Right cavernous sinus</td><td align="center" valign="middle" >Headache, ptosis</td><td align="center" valign="middle" >Subtotal</td><td align="center" valign="middle" >Yes/No</td><td align="center" valign="middle" >No recurrence</td></tr><tr><td align="center" valign="middle" >Wu C 2011 [<xref ref-type="bibr" rid="scirp.77422-ref14">14</xref>]</td><td align="center" valign="middle" >36/M</td><td align="center" valign="middle" >Right</td><td align="center" valign="middle" >Right cavernous sinus</td><td align="center" valign="middle" >N/A</td><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >No/No</td><td align="center" valign="middle" >N/A</td></tr><tr><td align="center" valign="middle" >Munoz-hidalgo 2014 [<xref ref-type="bibr" rid="scirp.77422-ref15">15</xref>]</td><td align="center" valign="middle" >15/M</td><td align="center" valign="middle" >Right</td><td align="center" valign="middle" >Right temporal</td><td align="center" valign="middle" >Headache, vomiting</td><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >No/No</td><td align="center" valign="middle" >No recurrence</td></tr><tr><td align="center" valign="middle" >Hongxu Chen 2015 [<xref ref-type="bibr" rid="scirp.77422-ref16">16</xref>]</td><td align="center" valign="middle" >20/F</td><td align="center" valign="middle" >Left</td><td align="center" valign="middle" >Left cerebellar hemisphere</td><td align="center" valign="middle" >Headache</td><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >No/No</td><td align="center" valign="middle" >N/A</td></tr><tr><td align="center" valign="middle" >Mohammad Samadian 2015 [<xref ref-type="bibr" rid="scirp.77422-ref17">17</xref>]</td><td align="center" valign="middle" >19/M</td><td align="center" valign="middle" >Left</td><td align="center" valign="middle" >Left temporal</td><td align="center" valign="middle" >Seizure</td><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >No/No</td><td align="center" valign="middle" >No recurrence</td></tr></tbody></table></table-wrap><table-wrap id="1_2"><caption><title> (c)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Author/Year</th><th align="center" valign="middle" >Age/sex</th><th align="center" valign="middle" >Naevus of Ota</th><th align="center" valign="middle" >Site of intracranial lesion</th><th align="center" valign="middle" >Presenting symptoms</th><th align="center" valign="middle" >Excision</th><th align="center" valign="middle" >RT/chemo</th><th align="center" valign="middle" >Outcome</th></tr></thead><tr><td align="center" valign="middle" >Marta Navas 2009 [<xref ref-type="bibr" rid="scirp.77422-ref18">18</xref>]</td><td align="center" valign="middle" >25/M</td><td align="center" valign="middle" >Right</td><td align="center" valign="middle" >Right temporal</td><td align="center" valign="middle" >Right CN3 palsy</td><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >No/No</td><td align="center" valign="middle" >Died post-op due to malignant infarct of right hemisphere</td></tr><tr><td align="center" valign="middle" >Shin 2015 [<xref ref-type="bibr" rid="scirp.77422-ref19">19</xref>]</td><td align="center" valign="middle" >56/F</td><td align="center" valign="middle" >Right</td><td align="center" valign="middle" >Left temporal</td><td align="center" valign="middle" >Headache, confusion</td><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >Yes/No</td><td align="center" valign="middle" >No recurrence</td></tr></tbody></table></table-wrap><table-wrap id="1_3"><caption><title></title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Author/Year</th><th align="center" valign="middle" >Age/sex</th><th align="center" valign="middle" >Naevus of Ota</th><th align="center" valign="middle" >Site of intracranial lesion</th><th align="center" valign="middle" >Presenting symptoms</th><th align="center" valign="middle" >Excision</th><th align="center" valign="middle" >RT/chemo</th><th align="center" valign="middle" >Outcome</th></tr></thead><tr><td align="center" valign="middle" >Enriquez 1973 [<xref ref-type="bibr" rid="scirp.77422-ref20">20</xref>]</td><td align="center" valign="middle" >43/M</td><td align="center" valign="middle" >N/A</td><td align="center" valign="middle" >Pineal, meningeal</td><td align="center" valign="middle" >N/A</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >No/No</td><td align="center" valign="middle" >Death</td></tr><tr><td align="center" valign="middle" >Sang DN 1977 [<xref ref-type="bibr" rid="scirp.77422-ref21">21</xref>]</td><td align="center" valign="middle" >58/M</td><td align="center" valign="middle" >Left</td><td align="center" valign="middle" >Right frontal</td><td align="center" valign="middle" >Headache, incontinence, left CN7 palsy</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >Yes/No</td><td align="center" valign="middle" >Mass similar with no progression 6 months later</td></tr><tr><td align="center" valign="middle" >Horsey 1980 [<xref ref-type="bibr" rid="scirp.77422-ref22">22</xref>]</td><td align="center" valign="middle" >37/F</td><td align="center" valign="middle" >Left</td><td align="center" valign="middle" >Left parietal, left temporal bone</td><td align="center" valign="middle" >Headache, CN6 palsy, nausea, vomiting</td><td align="center" valign="middle" >Total (parietal)</td><td align="center" valign="middle" >Yes/No</td><td align="center" valign="middle" >No recurrence</td></tr><tr><td align="center" valign="middle" >Sagar HJ 1983 [<xref ref-type="bibr" rid="scirp.77422-ref23">23</xref>]</td><td align="center" valign="middle" >23/F</td><td align="center" valign="middle" >Right</td><td align="center" valign="middle" >Right temporal</td><td align="center" valign="middle" >Partial seizure</td><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >No/No</td><td align="center" valign="middle" >No recurrence</td></tr><tr><td align="center" valign="middle" >Kubato 1988 [<xref ref-type="bibr" rid="scirp.77422-ref24">24</xref>]</td><td align="center" valign="middle" >77/M</td><td align="center" valign="middle" >Left</td><td align="center" valign="middle" >Left temporal</td><td align="center" valign="middle" >Disturbed consciousness, left hemiparesis</td><td align="center" valign="middle" >Subtotal</td><td align="center" valign="middle" >No/Yes</td><td align="center" valign="middle" >Death 3 weeks post op</td></tr><tr><td align="center" valign="middle" >Hartmann LC 1989 [<xref ref-type="bibr" rid="scirp.77422-ref25">25</xref>]</td><td align="center" valign="middle" >41/F</td><td align="center" valign="middle" >Right</td><td align="center" valign="middle" >Right middle fossa</td><td align="center" valign="middle" >Headache</td><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >No/No</td><td align="center" valign="middle" >Recur 6 months later. Observe. FU 1 year post op unchanged</td></tr><tr><td align="center" valign="middle" >Johnson RR 1999 [<xref ref-type="bibr" rid="scirp.77422-ref26">26</xref>]</td><td align="center" valign="middle" >42/M</td><td align="center" valign="middle" >Left</td><td align="center" valign="middle" >Left occipital</td><td align="center" valign="middle" >Headache, right upper quadrantonopia, scotoma</td><td align="center" valign="middle" >Subtotal</td><td align="center" valign="middle" >Yes/No</td><td align="center" valign="middle" >Static residual mass 3 months post-op</td></tr><tr><td align="center" valign="middle" >Azar 2010 [<xref ref-type="bibr" rid="scirp.77422-ref27">27</xref>]</td><td align="center" valign="middle" >21/M</td><td align="center" valign="middle" >Left</td><td align="center" valign="middle" >Right parietal, right retrobulbar, right cavernous sinus</td><td align="center" valign="middle" >Left hemiparesis + headache</td><td align="center" valign="middle" >Total (parietal)</td><td align="center" valign="middle" >Yes/Yes</td><td align="center" valign="middle" >Melanoma dissemination</td></tr></tbody></table></table-wrap><table-wrap id="1_4"><caption><title></title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Wang J 2013 [<xref ref-type="bibr" rid="scirp.77422-ref28">28</xref>]</th><th align="center" valign="middle" >52/F</th><th align="center" valign="middle" >Left</th><th align="center" valign="middle" >Left temporal</th><th align="center" valign="middle" >Recurrence of previous melanoma on MRI (16 months post-op)</th><th align="center" valign="middle" >Total</th><th align="center" valign="middle" >No/No</th><th align="center" valign="middle" >No recurrence</th></tr></thead><tr><td align="center" valign="middle" >Wang J 2013 [<xref ref-type="bibr" rid="scirp.77422-ref28">28</xref>]</td><td align="center" valign="middle" >33/F</td><td align="center" valign="middle" >Left</td><td align="center" valign="middle" >Left tentorium cerebelli</td><td align="center" valign="middle" >Headache, left facial numbness</td><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >No/No</td><td align="center" valign="middle" >No recurrence</td></tr><tr><td align="center" valign="middle" >Bharat Guthikonda 2015 [<xref ref-type="bibr" rid="scirp.77422-ref29">29</xref>]</td><td align="center" valign="middle" >32/F</td><td align="center" valign="middle" >Left</td><td align="center" valign="middle" >Right frontotemporal</td><td align="center" valign="middle" >Left side numbness</td><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >No/No</td><td align="center" valign="middle" >N/A</td></tr></tbody></table></table-wrap></table-wrap-group><p>46% in those whose resection was incomplete. However, the survival rate improved to 100% in patients with incomplete resection and adjunct radiation therapy. Based on this, they concluded that complete tumor resection is the best therapeutic option, and in cases of incomplete resection, radiotherapy should be considered [<xref ref-type="bibr" rid="scirp.77422-ref30">30</xref>] .</p><p>A retrospective review published by Rodriguez Y in 1992 on 81 cases of primary solitary intracranial melanoma also showed similar improved survival (19.6 &#177; 2.3 months) in patients with complete removal of the tumour than patients undergoing partial removal or biopsy (9.3 &#177; 2.4 months). Patients who were not operated had a shorter survival than both surgical subgroups of patients [<xref ref-type="bibr" rid="scirp.77422-ref31">31</xref>] .</p><p>Unfortunately, based on the above literature review, follow up data for patients with naevus of Ota and CNS melanocytic neoplasm is lacking and heterogeneous. However, from the limited evidence available, we can conclude that recurrence and even metastasis of the previously thought to be benign melanocytoma is not uncommon. Therefore, follow up with regular imaging is important.</p></sec><sec id="s4"><title>4. Conclusions</title><p>Primary CNS intermediate grade melanocytic neoplasm and concomitant nevus of Ota have been rarely reported. This is the third reported case in literature so far. It is made more unique due to the fact that this is the first reported case in which a familial naevus of Ota occurs together with an intracranial melanocytic lesion.</p><p>There is no standard treatment protocol for intermediate grade melanocytic neoplasm occurring simultaneously with a Nevus of Ota. Based on data extrapolated from treatment for meningeal melanocytoma and primary intracranial melanoma, we propose that complete surgical excision should be considered as the best therapeutic option. Close monitoring with imaging of patients with intermediate grade melanocytic neoplasm post-operatively is important.</p></sec><sec id="s5"><title>Cite this paper</title><p>Hung, D.S.W., Mak, C.H.K. and Cheung, F.C. (2017) Intracranial Intermediate-Grade Melanocytic Neoplasm: Case Report Associated with Nevus of Ota. Open Journal of Modern Neurosurgery, 7, 65-74. https://doi.org/10.4236/ojmn.2017.73008</p></sec></body><back><ref-list><title>References</title><ref id="scirp.77422-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Ota, M. (1939) Nevus Fusco-Caeruleus-Ophthalmo-Maxillaris. The Japanese Journal of Dermatology, 46, 369.</mixed-citation></ref><ref id="scirp.77422-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Liubinas, S.V., Maartens, N. and Drummond, K.J. (2010) Primary Melanocytic Neoplasms of the Central Nervous System. Journal of Clinical Neuroscience, 17, 1227-1232. https://doi.org/10.1016/j.jocn.2010.01.017</mixed-citation></ref><ref id="scirp.77422-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Jaiswal, S., Vij, M., Tungria, A., Jaiswal, A.K., Srivastava, A.K. and Behari, S. (2011) Primary Melanocytic Tumors of the Central Nervous System: A Neuroradiological and Clinicopathological Study of Five Cases and Brief Review of Literature. Neurology India, 59, 413-419. https://doi.org/10.4103/0028-3886.82758</mixed-citation></ref><ref id="scirp.77422-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Brat, D.J., Giannini, C., Scheithauer, B.W. and Burger, P.C. (1999) Primary Melanocytic Neoplasms of the Central Nervous Systems. The American Journal of Surgical Pathology, 23, 745-754. https://doi.org/10.1097/00000478-199907000-00001</mixed-citation></ref><ref id="scirp.77422-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Abeygunaratne, R., Roberts, G., Gunawardena, L., Joseph, J. and Dawson, T. (2008) Final Diagnosis—Primary CNS Melanocytic Tumor of Intermediate Type Progressing to Metastatic Melanoma. University of Pittsburgh, Pittsburgh.</mixed-citation></ref><ref id="scirp.77422-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Wang, F., Qiao, G., Lou, X., Song, X. and Chen, W. (2010) Malignant Transformation of Intracranial Meningeal Melanocytoma. Case Report and Review of the Literature. Neuropathology, 31, 414-420.  
https://doi.org/10.1111/j.1440-1789.2010.01160.x</mixed-citation></ref><ref id="scirp.77422-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Boticelli, A.R., Villani, M., Angiari, P. and Peserico, L. (1983) Meningeal Melanocytoma of Meckel’s Cave Associated with Ipsilateral Ota’s Nevus. Cancer, 51, 2304-2310.  
https://doi.org/10.1002/1097-0142(19830615)51:12&lt;2304::AID-CNCR2820511223&gt;3.0.CO;2-U</mixed-citation></ref><ref id="scirp.77422-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Moon, W.S., Kim, J.H., Lee, D.G., Choi, Y.H. and Kim, S.S. (1992) Meningeal Melanocytoma Associated with Ota’s Nevus. Report of a Case. The Korean Journal of Pathology, 26, 605-609.</mixed-citation></ref><ref id="scirp.77422-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Piercecchi-Marti, M.-D., Mohamed, H., Liprandi, A., Gambarelli, D., Grisoli, F. and Pellissier, J.-F. (2002) Intracranial Meningeal Melanocytoma Associated with Ipsilateral Nevus of Ota. Journal of Neurosurgery, 96, 619-623.  
https://doi.org/10.3171/jns.2002.96.3.0619</mixed-citation></ref><ref id="scirp.77422-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Rahimi-Movaghar, V. and Karimi, M. (2003) Meningeal Melanocytoma of the Brain and Oculodermal Melanocytosis (Nevus of Ota): Case Report and Literature Review. Neurosurgery, 59, 200-210. https://doi.org/10.1016/S0090-3019(02)01052-2</mixed-citation></ref><ref id="scirp.77422-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Rutten, I., Bolle, S., Kaschten, B., Stevenaert, A., Deneufbourg, J.-M. and Deprez, M. (2005) Recurrent Intracranial Melanocytoma Associated with a Nevus of Ota. Acta Neurochirurgica, 147, 313-315.</mixed-citation></ref><ref id="scirp.77422-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Hino, K., Nagane, M., Fujioka, Y. and Shiokawa, Y. (2005) Meningeal Melanocytoma Associated with Ipsilateral Nevus of Ota Presenting as Intracerebral Hemorrhage: Case Report. Neurosurgery, 56, 1376–1377.  
https://doi.org/10.1227/01.NEU.0000159716.45457.BC</mixed-citation></ref><ref id="scirp.77422-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Pan, H., Wang, H. and Fan, Y. (2011) Intracranial Meningeal Melanocytoma Associated with Nevus of Ota. Journal of Clinical Neuroscience, 18, 1548-1550.</mixed-citation></ref><ref id="scirp.77422-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Wu, C., Wang, H., Shi, Q.L., Ma, H.H. and Lu, Z.F. (2011) Meningeal Melanocytoma with Nevus Fuscoceruleusophthalmomaxillaris: Report of a Case. Chinese Journal of Pathology, 40, 194-195.</mixed-citation></ref><ref id="scirp.77422-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Munoz-Hidalgo, L., Lopez-Gines, C., Navarro, L., Callaghan, R.C., San Miguel, T., Gil-Benso, R., Quilis, V., Botella, L., Gonzalez-Darder, J. and Cerda-Nicolas, M. (2014) BRAF V600E Mutation in Two Distinct Meningeal Melanocytomas Associated with a Nevus of Ota. Journal of Clinical Oncology, 32, e72-e75.  
https://doi.org/10.1200/JCO.2013.48.8718</mixed-citation></ref><ref id="scirp.77422-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Chen, H., Liu, W., Zhang, S., Xu, J. and Hui, X. (2015) Cerebellar Meningeal Melanocytoma Associated with Nevus of Ota: An Extremely Rare Case.</mixed-citation></ref><ref id="scirp.77422-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Samadian, M., Nejad, A.M., Bakhtevari, M.H., Sabeti, S., Sharifi, G., Jabbari, R. and Rezaei, O. (2015) Primary Meningeal Melanocytoma in the Left Temporal Lobe Associated with Nevus Ota: A Case Report and Review of the Literature. Journal of Neurosurgery, 95, 225-231.</mixed-citation></ref><ref id="scirp.77422-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Navas, M., Pascual, J.M., Fraga, J., Pedrosa, M., Shakur, S., Carrasco, R., Martínez, P., Manzanares, R. and de Sola, R.G. (2009) Intracranial Intermediate-Grade Meningeal Melanocytoma with Increased Cellular Proliferative Index: An Illustrative Case Associated with a Nevus of Ota. Journal of Neuro-Oncology, 95, 105-115.  
https://doi.org/10.1007/s11060-009-9907-3</mixed-citation></ref><ref id="scirp.77422-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Shin, D., Sinha, M., Kondziolka, D.S., Kirkwood, J.M., Rao, U.N. and Tarhini, A.A. (2015) Intermediate-Grade Meningeal Melanocytoma Associated with Nevus of Ota: A Case Report and Review of the Literature. Melanoma Research, 25, 273-278.  
https://doi.org/10.1097/CMR.0000000000000163</mixed-citation></ref><ref id="scirp.77422-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Enriques, R. and Egbert, B. (1973) Primary Malignant Melanoma of Central Nervous System. Archives of Pathology, 95, 392-395.</mixed-citation></ref><ref id="scirp.77422-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Sang, D.N., Albert, D.M., Sober, A.J. and McMeekin, T.O. (1977) Nevus of Ota with Contralateral Cerebral Melanoma. Archives of Ophthalmology, 95, 1820-1824.  
https://doi.org/10.1001/archopht.1977.04450100122017</mixed-citation></ref><ref id="scirp.77422-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Horsey, W.J., Bilbao, J.M., Nethercott, J., Myers, R. and Hoffman, H.J. (1980) University of Toronto Neurosurgical Rounds No. 2. Oculodermalmelanosis (Naevus of Ota) Complicated by Multiple Intracranial Tumors. The Canadian Journal of Neurological Sciences, 7, 101-107. https://doi.org/10.1017/S0317167100023477</mixed-citation></ref><ref id="scirp.77422-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Sagar, H.J., Ilgren, E.B. and Adams, C.B. (1983) Nevus of Ota Associated with Meningeal Melanosis and Intracranial Melanoma. Case Report. Journal of Neurosurgery, 58, 280-283. https://doi.org/10.3171/jns.1983.58.2.0280</mixed-citation></ref><ref id="scirp.77422-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Kabuto, M., Hayashi, M., Kawano, H., Kobayashi, H., Shirasaki, N., Hirose, S., Kubota, T. and Sugihara, H. (1988) Primary Intracranial Malignant Melanoma Associated with Nevus of Ota: A Case Report. No Shinkei Geka, 16, 875-880.</mixed-citation></ref><ref id="scirp.77422-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Hartmann, L.C., Oliver, G.F., Winkelmann, R.K., Colby, T.V., Sundt, T.M. and O’Neill, B.P. (1989) Blue Nevus and Nevus of Ota Associated with Dural Melanoma. Cancer, 64, 182-186.  
https://doi.org/10.1002/1097-0142(19890701)64:1&lt;182::AID-CNCR2820640131&gt;3.0.CO;2-P</mixed-citation></ref><ref id="scirp.77422-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Johnson, R.R., Wong, J.H., Awad, I.A., Kim, J.H., Bolognia, J.L. and Sawaya, R. (1999) Hemorrhagic Lesion at the Tentorial Incisura in a Patient with Facial Nevus. Neurosurgery, 45, 1216-1221.</mixed-citation></ref><ref id="scirp.77422-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Azar, M., Kazemi, F., Bahrami, E., Hejazian, E., Fereshtehnejad, S.-M., Ahmadi, A. and Yasari, M. (2010) Meningeal Melanomas Associated with Transforming Ota Nevus to Malignant Melanoma: A Case Report. Medical Journal of the Islamic Republic of Iran, 24, 163-168.</mixed-citation></ref><ref id="scirp.77422-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Wang, J., Guo, Z.Z., Zhang, S.G., Wang, Y.J., Wang, Y.B. and Xing, D.G. (2013) Microsurgical Treatment of Meningeal Malignant Melanoma Accompanied by Nevus of Ota: Two Case Reports and a Literature Review. Melanoma Research, 23, 502-504. https://doi.org/10.1097/CMR.0000000000000026</mixed-citation></ref><ref id="scirp.77422-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Guthikonda, B., Ahmed, O., Buckleair, L.J., Goodman, J.C., Powell, S.Z. and Yoshor, D. (2015) Primary CNS Malignant Melanoma Associated With a Contralateral Nevus of Ota in an African-American Female: Unique Case Report. Cancer and Clinical Oncology, 4.</mixed-citation></ref><ref id="scirp.77422-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Rades, D., Schild, S.E., Tatagiba, M., Molina, H.A. and Alberti, W. (2004) Therapy of Meningeal Melanocytomas. Cancer, 100, 2442-2447.  
https://doi.org/10.1002/cncr.20296</mixed-citation></ref><ref id="scirp.77422-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Rodriguezy Baena, R., Gaetani, P., Danova, M., Bosi, F. and Zappoli, F. (1992) Primary Solitary Intracranial Melanoma: Case Report and Review of the Literature. Surgical Neurology, 38, 26-37.</mixed-citation></ref></ref-list></back></article>